The Benchmark Company initiated coverage on BioSig Technologies with a new price target

2/8/21 7:32:50 AM ET

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

The Benchmark Company initiated coverage of BioSig Technologies with a rating of Buy and set a new price target of $42.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$BSGM

Date	Price Target	Rating	Analyst